They are a newly organized blank check company. While they may pursue an acquisition opportunity in any business, industry, sector or geographical location, they intend to focus on industries that complement their management team’s background, and to capitalize on the ability of their management team to identify and acquire a business, focusing on the healthcare industry, with an emphasis on the biotechnology sector where their management has extensive investment experience. Their sponsor is an affiliate of RA Capital, a leading life sciences focused investment firm with over $7 billion of regulatory assets under management as of December 31, 2020. Since its launch in 2002, RA Capital has focused exclusively on the healthcare industry. Peter Kolchinsky, PhD, their founding Chairman and Chief Executive Officer, founded RA Capital, where he is a Managing Partner. Matthew Hammond, PhD, their founding Chief Investment Officer and Director and Tess Cameron, their founding Chief Financial Officer and Director, are Principals on the investment team at RA Capital.